Lindus

Lindus is a next-generation CRO, engineered to give biotech and pharma sponsors confidence and control to generate clinical data on time and on budget. Citrus™, an AI-assisted trial operating system with clinical oversight, connects patient identification across 40 million EHRs to full-scope execution across the US and UK. Lindus has delivered over 45 trials across cardiometabolic, respiratory, psychiatry, dermatology, women's health, and diagnostics. In trials where Lindus owned enrollment, 82% completed on or ahead of the timeline presented at proposal. Milestone-based payments align incentives around timelines and budgets. The company is backed by leading investors and advisors, including Peter Thiel and Prof. Robert S. Langer.